JWC: The hidden costs of limiting access: clinical and economic risks of Medicare's future effective cellular, acellular and matrix-like products (CAMPs) Local Coverage Determination

 

Published online and in Journal of Wound Care 1 May 2025 Volume 34 Issue Sup 5 the article evaluates the impact of Medicare's future effective Local Coverage Determination (LCD) for cellular, acellular and matrix-like products (CAMPs), which, while informed by a literature review and expert input, was finalised without incorporating a detailed statistical or cost analysis of its projected clinical and economic impact across diverse wound care delivery settings (e.g., hospital-affiliated, private practice, and post-acute care).


William Tettelbach, David Armstrong, Jeffery Niezgoda, Naz Wahab, Windy Cole, Travis Tucker, Martha R Kelso


 
Next
Next

CMS Statement on Local Coverage Determination for Certain Skin Substitute Grafts